Jared Seehafer

Jared Seehafer serves as the CEO and Co-Founder of Enzyme, a company he co-founded in 2017. He brings a robust 15-year background in the medical device and biopharma sectors, with a focus on product management, digital health, and regulatory strategy. Seehafer’s career includes significant roles such as leading spinal cord stimulator programs at St. Jude Neuromodulation (now part of Abbott) and working on the user interface and user experience for Medtronic Diabetes’s first hybrid closed loop insulin pump. He has also managed regulatory strategy and submissions for several combination drug-device products, including Amgen’s Neulasta Onpro and Repatha Pushtronex. Throughout his career, Seehafer has represented over two dozen companies in their interactions with the FDA and equivalent international regulatory bodies. He holds an MS in Medical Device Engineering from the University of Southern California, a BA in Molecular Biology, and a Regulatory Affairs Certification (RAC) from the Regulatory Affairs Professionals Society (RAPS). His areas of expertise are deeply rooted in regulatory strategy and submissions, digital health, regulated software development, and product management.